Cargando…

Counting the cost of COVID-19 at the peak of the pandemic in Spain

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585728/ https://www.ncbi.nlm.nih.gov/pubmed/34785880 http://dx.doi.org/10.1007/s40274-021-08165-9

Ejemplares similares

Increase in thromboembolic ADRs from oral contraceptives during COVID-19 pandemic in Spain
Publicado: (2022)

Costs of ICU care during COVID-19 pandemic in USA
Publicado: (2021)

Estimated direct costs of COVID-19 pandemic high in Turkey, but true costs "undoubtedly higher"
Publicado: (2021)

Impact of the first COVID-19 pandemic peak and lockdown on the interventional management of carotid artery stenosis in France
por: Crespy, Valentin, et al.
Publicado: (2022)

Association between Peak Neutrophil Count, Clopidogrel Loading Dose, and Left Ventricular Systolic Function in Patients with Primary Percutaneous Coronary Intervention
por: Wang, Xinyu, et al.
Publicado: (2014)

COVID-19 pandemic associated with substantial costs in older Medicare beneficiaries
Publicado: (2021)

An overview of the situation of hand surgery in Spain during the peak of COVID-19 pandemic
por: Martin-Playa, P., et al.
Publicado: (2020)

Appropriateness of Emergency CT Utilization During the Initial Peak of the COVID-19 Pandemic
por: Bruno, Michael A., et al.
Publicado: (2020)

National lockdown not cost effective in Israel during COVID-2 pandemic
Publicado: (2021)

Costs of active COVID-19 testing in Canada
Publicado: (2020)

Cost-benefit of COVID-19 lockdown in the UK
Publicado: (2020)

Anxiety About the Risk of Death of Their Patients in Health Professionals in Spain: Analysis at the Peak of the COVID-19 Pandemic
por: Lázaro-Pérez, Cristina, et al.
Publicado: (2020)

Changes in Peak Flow Value during Immunotherapy Administration
por: Saporta, Diego
Publicado: (2012)

Testing and restrictions are cost-effective COVID-19 measures
Publicado: (2021)

Remdesivir cost effective for severe COVID-19 in China
Publicado: (2021)

COVID-19 vaccination predicted to be cost effective in USA
Publicado: (2021)

Cost effective COVID-19 mitigation measures in US colleges
Publicado: (2021)

Rapid COVID-19 movement restrictions reduce societal costs
Publicado: (2021)

Productivity losses impact cost effectiveness of COVID-19 vaccine
Publicado: (2021)

Tocilizumab cost effective in reducing COVID-19-related deaths
Publicado: (2021)

Expanded testing for COVID-19 could be cost effective in USA
Publicado: (2020)

COVID-19 control strategies cost effective in South Africa
Publicado: (2020)

Counting the cost of COVID-19
por: Yamin, Mohammad
Publicado: (2020)

Effects of control measures on the dynamics of COVID-19 and double-peak behavior in Spain
por: Huang, Jianzhe, et al.
Publicado: (2020)

Easing of COVID-19 social restrictions in England comes at a cost
Publicado: (2021)

Effects on LOS may not justify cost of remdesivir for severe COVID-19
Publicado: (2021)

ICU bed reserve capacity for COVID-19 cost effective in Germany
Publicado: (2021)

Expediting COVID-19 vaccination increases QALYs and saves costs in the USA
Publicado: (2021)

Substantial direct medical costs for symptomatic COVID-19 cases in the US
Publicado: (2020)

When will the Covid-19 pandemic peak?()
por: Li, Shaoran, et al.
Publicado: (2021)

Universal COVID-19 vaccination cost saving unless anaphylaxis rate high
Publicado: (2021)

Effects of Atorvastatin on Resting and Peak Exercise Blood Pressure among Normotensive Men and Women
por: Zaleski, Amanda L., et al.
Publicado: (2014)

Impact of the COVID-19 pandemic on neuro-oncology outcomes
por: Norman, Sofya, et al.
Publicado: (2021)

Protecting Healthcare Professionals during the COVID-19 Pandemic
por: Qi, Baiwen, et al.
Publicado: (2020)

Effects of the COVID-19 Pandemic on Pediatric Nasal Fractures
por: Firat Koca, Cigdem, et al.
Publicado: (2022)

Single centre concept of ‘cold site’ elective surgery during the peak of COVID-19 pandemic : A cohort study
por: Iqbal, Muhammad Rafaih, et al.
Publicado: (2020)

Counting the neurological cost of COVID-19
por: Baig, Abdul Mannan
Publicado: (2021)

Baricitinib + SOC cost effective vs SOC for patients hospitalised with COVID-19 in the USA
Publicado: (2021)

Remdesivir may be cost saving in eligible patients during COVID-19 infections in Germany
Publicado: (2021)

Baricitinib + remdesivir cost saving vs remdesivir for hospitalised COVID-19 patients in the USA
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_iv7097lisa4lq00gl0706jt0qr